Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration
1.4.2 North America Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel
1.4.3 North America Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication
1.4.4 North America Non-steroidal Anti-inflammatory Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Strategies deployed in Non-steroidal Anti-inflammatory Drugs Market
Chapter 4. North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
4.1 North America Oral Market by Country
4.2 North America Topical Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
5.1 North America Retail Pharmacy Market by Country
5.2 North America Hospital Pharmacy Market by Country
5.3 North America Online Pharmacy Market by Country
Chapter 6. North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
6.1 North America Arthritis Market by Country
6.2 North America Migraine Market by Country
6.3 North America Ophthalmic Diseases Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Non-steroidal Anti-inflammatory Drugs Market by Country
7.1 US Non-steroidal Anti-inflammatory Drugs Market
7.1.1 US Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.1.2 US Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.1.3 US Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.2 Canada Non-steroidal Anti-inflammatory Drugs Market
7.2.1 Canada Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.2.2 Canada Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.2.3 Canada Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.3 Mexico Non-steroidal Anti-inflammatory Drugs Market
7.3.1 Mexico Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.3.2 Mexico Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.3.3 Mexico Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.4 Rest of North America Non-steroidal Anti-inflammatory Drugs Market
7.4.1 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.4.2 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.4.3 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
Chapter 8. Company Profiles
8.1 Dr. Reddy’s Laboratories Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals and Trails:
8.3 GlaxoSmithKline PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals and Trails:
8.4 Bayer AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trails:
8.5 Teva Pharmaceutical Industries Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Eli Lilly And Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Approvals and Trails:
8.7 Sanofi S.A.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 AstraZeneca PLC
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.9 Viatris, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
Unique Offerings 